A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.

Safer, Debra L; Adler, Sarah; Dalai, Shebani Sethi; Bentley, Jason P; Toyama, Hannah; Pajarito, Sarah; Najarian, Thomas

Safer, Debra L; Adler, Sarah; Dalai, Shebani Sethi; Bentley, Jason P; Toyama, Hannah; Pajarito, Sarah; Najarian, Thomas.

Afiliação

Safer DL; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Adler S; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Dalai SS; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Bentley JP; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California.
Toyama H; Department of Psychology, Palo Alto University, Palo Alto, California.
Pajarito S; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Najarian T; Najarian Center for Obesity, Los Osos, California.

Int J Eat Disord ; 53(2): 266-277, 2020 02.

Article em En | MEDLINE | ID: mdl-31721257

Assuntos

Transtorno da Compulsão Alimentar/tratamento farmacológico; Bulimia Nervosa/tratamento farmacológico; Fentermina/uso terapêutico; Topiramato/uso terapêutico; Adolescente; Adulto; Estudos Cross-Over; Combinação de Medicamentos; Feminino; Humanos; Pessoa de Meia-Idade; Fentermina/farmacologia; Topiramato/farmacologia; Adulto Jovem

Palavras-chave

Qsymia; binge-eating disorder; bulimia nervosa; clinical trial; crossover; eating disorder treatment; obesity; phentermine; topiramate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fentermina / Bulimia Nervosa / Transtorno da Compulsão Alimentar / Topiramato Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google